MG

Manas Gogoi

Active Director Director DIN 08527600
DIN 08527600 First appointment Aug 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2019
Shareholding value •••• Premium profile

About Manas Gogoi

Data last updated:

Manas Gogoi is a Director at Optimal Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Optimal Pharmaceuticals Private Limited reported revenue of ₹85 Lakh (FY 2025).

DIN 08527600
Primary Designation Director
Industry Pharma
First Appointment 02 Aug 2019
Oldest Company Age 7 yrs
Largest company Optimal Pharmaceuticals Private Limited · ₹85 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Aug 20192019₹85 Lakh (FY 2025)Active

Board colleagues of Manas Gogoi

NameDINCompanyDesignation
Avinash Upadhyay08527599Optimal Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Optimal Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Manas Gogoi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manas Gogoi

Manas Gogoi currently holds 1 directorship: Optimal Pharmaceuticals Private Limited (Director, since 02 Aug 2019, revenue ₹85 Lakh (FY 2025)).

Manas Gogoi was first appointed on 02 Aug 2019 as Director at Optimal Pharmaceuticals Private Limited.

The current boards of Manas Gogoi's companies include Avinash Upadhyay (Optimal Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available